News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Pfizer Inc. Executive, Martin Mackay Jumps Ship to Head AstraZeneca PLC’s R&D
May 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- AstraZeneca Plc said on Wednesday it had appointed Martin Mackay from Pfizer Inc (PFE.N) as its global head of research and development, while Pfizer named Mikael Dolsten as its new R&D leader.
Twitter
LinkedIn
Facebook
Email
Print
People
AstraZeneca Pharmaceuticals LP
Pfizer
MORE ON THIS TOPIC
Manufacturing
Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard
May 14, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Bayer, Leap, Atara Reduce Workforces Amid Strategic Reorganizations
May 14, 2025
·
204 min read
·
BioSpace Editorial Staff
Podcast
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
May 14, 2025
·
2 min read
·
Heather McKenzie
C-suite
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
May 13, 2025
·
2 min read
·
Annalee Armstrong
